Concepedia

Systemic Inflammatory Response Markers and CA-125 Levels in Ovarian Clear Cell Carcinoma: A Two Center Cohort Study

Hee Seung Kim, Hwa-Young Choi, Maria Lee, Dong Hoon Suh, Kidong Kim, Jae Hong No, Hyun Hoon Chung, Yong Beom Kim, Yong Sang Song

Cancer Research and Treatment · 2015 · 75 citations · 15 references

DOIFull text

Open access

Abstract

CA-125 levels may be the most useful marker for predicting advanced-stage disease. Suboptimal debulking and platinum-resistance, and PLR and NLR may be most effective to predict non-CR and PFS in patients with OCCC.

References

15

Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Bernhard Nieswandt, Michael Häfner, Bernd Echtenacher et al. · PubMed · 1999 · 835 citations

, , +18

Definitions for Response and Progression in Ovarian Cancer Clinical Trials Incorporating RECIST 1.1 and CA 125 Agreed by the Gynecological Cancer Intergroup (GCIG)

Gordon John Sampson Rustin, Ignace Vergote, Elizabeth A. Eisenhauer et al. · International Journal of Gynecological Cancer · 2011 · 600 citations

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment

Hanbyoul Cho, Hye Won Hur, Sang Wun Kim et al. · Cancer Immunology Immunotherapy · 2008 · 526 citations · Full text

, , +7

Platelet to lymphocyte ratio as a prognostic factor for epithelial ovarian cancer

Supachai Raungkaewmanee, Siriwan Tangjitgamol, Sumonmal Manusirivithaya et al. · Journal of Gynecologic Oncology · 2012 · 254 citations · Full text

Preoperative platelet lymphocyte ratio as an independent prognostic marker in ovarian cancer

Viren Asher, Joanne Lee, Anni Innamaa et al. · Clinical & Translational Oncology · 2011 · 243 citations

, , +9